SASE:4007

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Al Hammadi Company For Development and Investment

Market Cap

ر.س4.9b

Last Updated

2021/07/23 14:03 UTC

Data Sources

Company Financials +

Executive Summary

Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Al Hammadi Company For Development and Investment's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4007 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 4007's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

0%

4007

0%

SA Healthcare

0%

SA Market


1 Year Return

57.4%

4007

75.1%

SA Healthcare

14.6%

SA Market

Return vs Industry: 4007 underperformed the SA Healthcare industry which returned 75.1% over the past year.

Return vs Market: 4007 exceeded the SA Market which returned 14.6% over the past year.


Shareholder returns

4007IndustryMarket
7 Day0%0%0%
30 Day5.5%-1.7%-1.1%
90 Day24.5%14.5%0.5%
1 Year59.7%57.4%78.0%75.1%19.0%14.6%
3 Year26.9%25.0%45.1%38.8%38.7%25.8%
5 Year8.8%5.1%56.4%43.8%99.6%69.1%

Long-Term Price Volatility Vs. Market

How volatile is Al Hammadi Company For Development and Investment's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Al Hammadi Company For Development and Investment undervalued compared to its fair value and its price relative to the market?

15.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 4007 (SAR40.45) is trading below our estimate of fair value (SAR47.78)

Significantly Below Fair Value: 4007 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 4007 is good value based on its PE Ratio (34.3x) compared to the SA Healthcare industry average (41x).

PE vs Market: 4007's PE Ratio (34.3x) is in line with the SA market.


Price to Earnings Growth Ratio

PEG Ratio: 4007 is poor value based on its PEG Ratio (2.2x)


Price to Book Ratio

PB vs Industry: 4007's PB Ratio (2.9x) is in line with the SA Healthcare industry average.


Future Growth

How is Al Hammadi Company For Development and Investment forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

15.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4007's forecast earnings growth (15.9% per year) is above the savings rate (8.8%).

Earnings vs Market: 4007's earnings (15.9% per year) are forecast to grow faster than the SA market (7.7% per year).

High Growth Earnings: 4007's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4007's revenue (7.1% per year) is forecast to grow faster than the SA market (3.7% per year).

High Growth Revenue: 4007's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4007's Return on Equity is forecast to be low in 3 years time (13.5%).


Past Performance

How has Al Hammadi Company For Development and Investment performed over the past 5 years?

4.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4007 has high quality earnings.

Growing Profit Margin: 4007's current net profit margins (13.3%) are higher than last year (9.9%).


Past Earnings Growth Analysis

Earnings Trend: 4007's earnings have grown by 4.7% per year over the past 5 years.

Accelerating Growth: 4007's earnings growth over the past year (50.8%) exceeds its 5-year average (4.7% per year).

Earnings vs Industry: 4007 earnings growth over the past year (50.8%) exceeded the Healthcare industry 23.8%.


Return on Equity

High ROE: 4007's Return on Equity (8.4%) is considered low.


Financial Health

How is Al Hammadi Company For Development and Investment's financial position?


Financial Position Analysis

Short Term Liabilities: 4007's short term assets (SAR796.6M) exceed its short term liabilities (SAR415.1M).

Long Term Liabilities: 4007's short term assets (SAR796.6M) exceed its long term liabilities (SAR405.1M).


Debt to Equity History and Analysis

Debt Level: 4007's debt to equity ratio (15.6%) is considered satisfactory.

Reducing Debt: 4007's debt to equity ratio has reduced from 39.3% to 15.6% over the past 5 years.

Debt Coverage: 4007's debt is well covered by operating cash flow (100.4%).

Interest Coverage: 4007's interest payments on its debt are well covered by EBIT (9.4x coverage).


Balance Sheet


Dividend

What is Al Hammadi Company For Development and Investment current dividend yield, its reliability and sustainability?

1.24%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4007's dividend (1.24%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.47%).

High Dividend: 4007's dividend (1.24%) is low compared to the top 25% of dividend payers in the SA market (4.5%).


Stability and Growth of Payments

Stable Dividend: 4007 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 4007 has only been paying a dividend for 6 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (42.4%), 4007's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 4007's dividends in 3 years are forecast to be covered by earnings (74.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average board tenure


CEO

Mohammad Bin Saleh Al Hammadi (50 yo)

25.5yrs

Tenure

Mr. Mohammad Bin Saleh Al Hammadi serves as an Executive Director & Managing Director at Al Hammadi Development and Investment Company. He has been an Owner of Al Hammadi Information Technology Establishme...


Board Members

Experienced Board: 4007's board of directors are considered experienced (5.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Al Hammadi Company For Development and Investment's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Al Hammadi Company For Development and Investment
  • Ticker: 4007
  • Exchange: SASE
  • Founded: 1985
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ر.س4.854b
  • Shares outstanding: 120.00m
  • Website: https://www.alhammadi.com

Location

  • Al Hammadi Company For Development and Investment
  • PO Box 55004
  • PO Box 55004
  • Riyadh
  • 11534
  • Saudi Arabia

Listings


Biography

Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services a...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/23 14:03
End of Day Share Price2021/07/15 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.